GT Biopharma, Inc. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
GT Biopharma, Inc. annual/quarterly Net Cash Provided by (Used in) Financing Activities history and growth rate from 2010 to 2023.
  • GT Biopharma, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2023 was $6.27M.
  • GT Biopharma, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $6.27M.
  • GT Biopharma, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$224K, a 101% decline from 2021.
  • GT Biopharma, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $42.3M, a 238% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $6.27M +$6.49M Jan 1, 2023 Dec 31, 2023 10-K 2024-03-26
2022 -$224K -$42.5M -101% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-26
2021 $42.3M +$29.8M +238% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-30
2020 $12.5M +$9.1M +266% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-28
2019 $3.43M -$6.77M -66.4% Jan 1, 2019 Dec 31, 2019 10-K 2021-04-16
2018 $10.2M +$4.21M +70.2% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-27
2017 $5.99M +$4.09M +215% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-29
2016 $1.9M -$1.95M -50.6% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-01
2015 $3.85M +$1.27M +49.1% Jan 1, 2015 Dec 31, 2015 10-K/A 2018-02-28
2014 $2.58M +$2.16M +508% Jan 1, 2014 Dec 31, 2014 10-K/A 2018-02-28
2013 $425K -$505K -54.3% Jan 1, 2013 Dec 31, 2013 10-K 2015-03-31
2012 $930K -$71K -7.09% Jan 1, 2012 Dec 31, 2012 10-K 2015-01-08
2011 $1M +$705K +238% Jan 1, 2011 Dec 31, 2011 10-K 2014-11-18
2010 $296K Jan 1, 2010 Dec 31, 2010 10-K 2012-04-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.